Abstract
The recent, fatal outbreak of the novel coronavirus strain in the Middle East highlights the real threat posed by this unique virus family. Neither pharmaceutical cures nor preventive vaccines are clinically available to fight against coronavirus associated syndromes, not to mention a lack of symptom soothing drugs. Development of treatment options is complicated by the unpredictable, recurring instances of cross-species viral transmission. The vastly distributing virus reservoir and the rapid rate of host-species exchange of coronavirus demands wide spectrum potency in an ideal therapeutic. Through summarizing the available information and progress in coronavirus research, this review provides a systematic assessment of the potential wide-spectrum features on the most popular drug targets including viral proteases, spike protein, RNA polymerases and editing enzymes as well as host-virus interaction pathways associated with coronaviruses.
Keywords: Coronavirus, Non-structural Proteins, SARS, Rational Drug Design, virus entry, Virus-Host Interaction, Main Protease.
Infectious Disorders - Drug Targets
Title:Drug Targets for Rational Design against Emerging Coronaviruses
Volume: 13 Issue: 2
Author(s): Qi Zhao, Erin Weber and Haitao Yang
Affiliation:
Keywords: Coronavirus, Non-structural Proteins, SARS, Rational Drug Design, virus entry, Virus-Host Interaction, Main Protease.
Abstract: The recent, fatal outbreak of the novel coronavirus strain in the Middle East highlights the real threat posed by this unique virus family. Neither pharmaceutical cures nor preventive vaccines are clinically available to fight against coronavirus associated syndromes, not to mention a lack of symptom soothing drugs. Development of treatment options is complicated by the unpredictable, recurring instances of cross-species viral transmission. The vastly distributing virus reservoir and the rapid rate of host-species exchange of coronavirus demands wide spectrum potency in an ideal therapeutic. Through summarizing the available information and progress in coronavirus research, this review provides a systematic assessment of the potential wide-spectrum features on the most popular drug targets including viral proteases, spike protein, RNA polymerases and editing enzymes as well as host-virus interaction pathways associated with coronaviruses.
Export Options
About this article
Cite this article as:
Zhao Qi, Weber Erin and Yang Haitao, Drug Targets for Rational Design against Emerging Coronaviruses, Infectious Disorders - Drug Targets 2013; 13 (2) . https://dx.doi.org/10.2174/18715265113139990024
DOI https://dx.doi.org/10.2174/18715265113139990024 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neurological Effects of SARS-CoV-2 and Neurotoxicity of Antiviral Drugs
Against COVID-19
Mini-Reviews in Medicinal Chemistry Biochemical, Molecular and Epigenetic Mechanisms of Valproic Acid Neuroprotection
Current Molecular Pharmacology Advances in Oncolytic Virus Therapy for Glioma
Recent Patents on CNS Drug Discovery (Discontinued) Neurological Manifestations of COVID-19 and the Importance of Magnetic Resonance Imaging
CNS & Neurological Disorders - Drug Targets Advances in Metabonomics on Infectious Diseases
Current Metabolomics Neuroimaging of Cancer Patients for Psychosocial Support and Patient Care
Current Medical Imaging The Importance of NAD in Multiple Sclerosis
Current Pharmaceutical Design Beyond Oncolytic Virotherapy: Replication-Competent Retrovirus Vectors for Selective and Stable Transduction of Tumors
Current Gene Therapy Recent Development and Future Prospects of Plant-Based Vaccines
Current Drug Metabolism Engineered Probiotic and Prebiotic Nutraceutical Supplementations in Combating Non-communicable Disorders: A Review
Current Pharmaceutical Biotechnology Aluminum Vaccine Adjuvants: Are they Safe?
Current Medicinal Chemistry Vaccine Development for Alzheimers Disease
Current Pharmaceutical Design Development of HIV Reservoir Targeted Long Acting Nanoformulated Antiretroviral Therapies
Current Medicinal Chemistry Trends and Applications of Brain Computer Interfaces
Current Signal Transduction Therapy Treatment of Viral Encephalitis
Central Nervous System Agents in Medicinal Chemistry Reviewing the Role of Resveratrol as a Natural Modulator of Microglial Activities
Current Pharmaceutical Design Assessment of Gene Transfer Using Imaging Methodology
Current Genomics Strain Typing of Mycoplasma pneumoniae and its Value in Epidemiology
Current Pediatric Reviews The Bananins: New Anticorona-RNA-Viral Agents with Unique Structural Signature
Anti-Infective Agents in Medicinal Chemistry Glycyrrhizic Acid Derivatives as New Antiviral and Immune Modulating Agents
Current Bioactive Compounds